|
1
|
Cao W, Chen HD, Yu YW, Li N and Chen WQ:
Changing profiles of cancer burden worldwide and in China: A
secondary analysis of the global cancer statistics 2020. Chin Med J
(Engl). 134:783–791. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cunningham D, Allum WH, Stenning SP,
Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ,
Falk SJ, Iveson TJ, et al: Perioperative chemotherapy versus
surgery alone for resectable gastroesophageal cancer. N Engl J Med.
355:11–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Al-Batran SE, Homann N, Pauligk C, Goetze
TO, Meiler J, Kasper S, Kopp HG, Mayer F, Haag GM, Luley K, et al:
Perioperative chemotherapy with fluorouracil plus leucovorin,
oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus
cisplatin and epirubicin for locally advanced, resectable gastric
or gastro-oesophageal junction adenocarcinoma (FLOT4): A
randomised, phase 2/3 trial. Lancet. 393:1948–1957. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bang YJ, Van Cutsem E, Feyereislova A,
Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T,
et al: Trastuzumab in combination with chemotherapy versus
chemotherapy alone for treatment of HER2-positive advanced gastric
or gastro-oesophageal junction cancer (ToGA): A phase 3,
open-label, randomised controlled trial. Lancet. 376:687–697. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sounni NE and Noel A: Targeting the tumor
microenvironment for cancer therapy. Clin Chem. 59:85–93. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and Metastasis. Nat Med.
19:1423–1437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oya Y, Hayakawa Y and Koike K: Tumor
microenvironment in gastric cancers. Cancer Sci. 111:2696–2707.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fuchs CS, Tomasek J, Yong CJ, Dumitru F,
Passalacqua R, Goswami C, Safran H, Dos Santos LV, Aprile G, Ferry
DR, et al: Ramucirumab monotherapy for previously treated advanced
gastric or gastro-oesophageal junction adenocarcinoma (REGARD): An
international, randomised, multicentre, placebo-controlled, phase 3
trial. Lancet. 383:31–39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kang YK, Boku N, Satoh T, Ryu MH, Chao Y,
Kato K, Chung HC, Chen JS, Muro K, Kang WK, et al: Nivolumab in
patients with advanced gastric or gastro-oesophageal junction
cancer refractory to, or intolerant of, at least two previous
chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised,
double-blind, placebo-controlled, phase 3 trial. Lancet.
390:2461–2471. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fuchs CS, Doi T, Jang RW, Muro K, Satoh T,
Machado M, Sun W, Jalal SI, Shah MA, Metges JP, et al: Safety and
efficacy of pembrolizumab monotherapy in patients with previously
treated advanced gastric and gastroesophageal junction cancer:
Phase 2 clinical KEYNOTE-059 trial. JAMA Oncol. 4:e1800132018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wilke H, Muro K, Van Cutsem E, Oh SC,
Bodoky G, Shimada Y, Hironaka S, Sugimoto N, Lipatov O, Kim TY, et
al: Ramucirumab plus paclitaxel versus placebo plus paclitaxel in
patients with previously treated advanced gastric or
gastro-oesophageal junction adenocarcinoma (RAINBOW): A
double-blind, randomised phase 3 trial. Lancet Oncol. 15:1224–1235.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng YB, Cao FY, Liu KJ, Gan HF, He XB
and Tong SL: Value of normalization window of tumor vasculature in
neoadjuvant chemotherapy for patients with unresectable gastric
cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 15:55–58. 2012.(In
Chinese). PubMed/NCBI
|
|
14
|
Sasaki A, Nakamura Y, Togashi Y, Kuno H,
Hojo H, Kageyama S, Nakamura N, Takashima K, Kadota T, Yoda Y, et
al: Enhanced tumor response to radiotherapy after PD-1 blockade in
metastatic gastric cancer. Gastric Cancer. 23:893–903. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jain RK: Normalizing tumor
microenvironment to treat cancer: Bench to bedside to biomarkers. J
Clin Oncol. 31:2205–2218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan B, Liu L, Zhao Y, Xiu LJ, Sun DZ, Liu
X, Lu Y, Shi J, Zhang YC, Li YJ, et al: Xiaotan Sanjie decoction
attenuates tumor angiogenesis by manipulating Notch-1-regulated
proliferation of gastric cancer stem-like cells. World J
Gastroenterol. 20:13105–13118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi J and Wei PK: The phlegm theory of
gastric cancer. Zhong Xi Yi Jie He Xue Bao. 9:581–587. 2011.(In
Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
18
|
State Administration of Traditional
Chinese Medicine, . Criteria for Diagnosis and Evaluation of
Therapeutic Effect on Diseases and Syndromes in Traditional Chinese
Medicine. Nanjing University Press; Nanjing: pp. 9–11. 1994
|
|
19
|
Sun DZ, Jiao JP, Ju DW, Ye M, Zhang X, Xu
JY, Lu Y, He J, Wei PK and Yang MH: Tumor interstitial fluid and
gastric cancer metastasis: An experimental study to verify the
hypothesis of ‘tumor-phlegm microenvironment’. Chin J Integr Med.
18:350–358. 2012.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ju DW, Wei PK, Lin HM, Sun DZ, Yu S and
Xiu LJ: Effects of Xiaotan Sanjie Decoction on expressions of
interleukin-8 and its receptors in gastric tumor xenografts and
gastric tissue adjacent to the tumor in mice. Zhong Xi Yi Jie He
Xue Bao. 8:74–79. 2010.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu X, Zhao Y, Wei P, Chen M, Jing J, Zhong
L, et al: Effects of Xiaotan Sanjie decoction on serum expression
levels of IL-8 and TGF-β in gastric tumor xenografts in nude mice.
Chin Arch Tradit Chin Med. 36:2382–2385. 2018.(In Chinese).
https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFDLAST2018&filename=ZYHS201810021&v=8GUmiMviuOMeRswXcUcanzXDS%25mmd2Bixowvul5WOa%25mmd2BraRlfuEWfwqoBiKhPNA6nOO6Ea
|
|
22
|
Ye M, Jiao J, Zhang X, et al: Xiaotan
Sanjie decoction inhibit MKN-45 human gastric cancer cells by
upregulating TGFβRII in vivo and in vitro. Chin J Clin. 11:596–601.
2017.(In Chinese). https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFDLAST2017&filename=ZLYD201704014&v=SSyny61gLr%25mmd2BD7csH5ElmOXxnrufLy1TFMCFLEq%25mmd2BKRZiigitzRn%25mmd2FLZPmCZon7uwML
|
|
23
|
Wang J, Wei P, Li Y and Xu L: Effects of
Xiaotan Sanjie decoction on expression of CD44V6 in MKN-45 human
gastric cancer nude mouse model. J Chengdu Univ Tradit Chin Med.
27:20–21. 2001.(In Chinese).
|
|
24
|
Gui MW, Wei PK, Lu Y, Guo W, Qin ZF and
Sun DZ: Effects of Xiaotan Sanjie Decoction-containing serum on
proliferation and apoptosis of human gastric cancer cells MKN-45.
Zhong Xi Yi Jie He Xue Bao. 8:250–255. 2010.(In Chinese).
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Xiu LJ, Jiao JP, Zhao J, Zhao Y, Lu
Y, Shi J, Li YJ, Ye M, Gu YF, et al: Traditional Chinese medicine
integrated with chemotherapy for stage IV non-surgical gastric
cancer: A retrospective clinical analysis. J Integr Med.
15:469–475. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun DZ, Li SD, Liu Y, Zhang Y, Mei R and
Yang MH: Differences in the origin of philosophy between Chinese
Medicine and Western medicine: Exploration of the holistic
advantages of Chinese medicine. Chin J Integr Med. 19:706–711.
2013.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
27
|
World Health Organization, . WHO
International Standard Terminologies on Traditional Medicine in the
Western Pacific Region, World Health Organization, Western Pacific
Region. 2007.https://asiantherapies.org/wp-content/uploads/2021/10/WHO-Terminology-Manual-1.pdf
|
|
28
|
Lu A, Jiang M, Zhang C and Chan K: An
integrative approach of linking traditional Chinese medicine
pattern classification and biomedicine diagnosis. J Ethnopharmacol.
141:549–556. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Clavey S: Phlegm: Aetiology and
symptomatology. In: Fluid Physiology and Pathology in Traditional
Chinese Medicine. Churchill Livingstone Elsevier; London: pp.
265–312. 2003
|
|
30
|
Meng Q: Basic Thoery of Traditional
Chinese Medicine. China Press of Traditional Chinese Medicine;
Beijing: 2005
|
|
31
|
Greenwood MT: Dysbiosis, Spleen Qi,
phlegm, and complex difficulties. Med Acupunct. 29:128–137. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yue X and Wei P: Phlegm as the target of
gastric cancer. Ti Erh Chun I Ta Hsueh Hsueh Pao. 39:1297–1301.
2018.
|
|
33
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ajani JA, D'Amico TA, Bentrem DJ, Chao J,
Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, et al:
Gastric cancer, version 2.2022, NCCN clinical practice guidelines
in oncology. J Natl Compr Canc Netw. 20:167–192. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guner A and Yildirim R: Surgical
management of metastatic gastric cancer: Moving beyond the
guidelines. Transl Gastroenterol Hepatol. 4:582019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Andreoli TE: Cecil essentials of medicine.
Elsevier; Philadelphia, PA: pp. 440–441. 2010
|
|
37
|
Shi J, Qin Z, Wang X, et al: Clinical
observation of TCM treatment of dispersing phlegm and eliminating
stagnation on postoperative gastric carcinoma. Chin J Info Tradit
Chin Med. 18:14–17. 2011.(In Chinese). https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFD2011&filename=XXYY201110010&v=WYxc3H1bWPb2I7WrEYpn3%25mmd2Bq7b0lH46oPvMqfiqxL2Kfg7dCZ%25mmd2FVE4dYKAbMYdugZR
|
|
38
|
Hsu PP and Sabatini DM: Cancer cell
metabolism: Warburg and beyond. Cell. 134:703–707. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gajewski TF, Meng Y, Blank C, Brown I,
Kacha A, Kline J and Harlin H: Immune resistance orchestrated by
the tumor microenvironment. Immunol Rev. 213:131–145. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fox JG and Wang TC: Inflammation, atrophy,
and gastric cancer. J Clin Invest. 117:60–69. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bockerstett KA and DiPaolo RJ: Regulation
of gastric carcinogenesis by inflammatory cytokines. Cell Mol
Gastroenterol Hepatol. 4:47–53. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sun H, Wang X, Wang X, Xu M and Sheng W:
The role of cancer-associated fibroblasts in tumorigenesis of
gastric cancer. Cell Death Dis. 13:8742022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Noël A, Gutiérrez-Fernández A, Sounni NE,
Behrendt N, Maquoi E, Lund IK, Cal S, Hoyer-Hansen G and López-Otín
C: New and paradoxical roles of matrix metalloproteinases in the
tumor microenvironment. Front Pharmacol. 3:1402012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bussard KM, Mutkus L, Stumpf K,
Gomez-Manzano C and Marini FC: Tumor-associated stromal cells as
key contributors to the tumor microenvironment. Breast Cancer Res.
18:842016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kinoshita H, Hirata Y, Nakagawa H,
Sakamoto K, Hayakawa Y, Takahashi R, Nakata W, Sakitani K, Serizawa
T, Hikiba Y, et al: Interleukin-6 mediates epithelial-stromal
interactions and promotes gastric tumorigenesis. PLoS One.
8:e609142013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bai J, Qi J, Yang L, Wang Z, Wang R and
Shi Y: A comprehensive review on ethnopharmacological,
phytochemical, pharmacological and toxicological evaluation, and
quality control of Pinellia ternata (Thunb.) Breit. J
Ethnopharmacol. 298:1156502022. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Song S, Huang W, Lu X, Liu J, Zhou J, Li Y
and Shu P: A network pharmacology study based on the mechanism of
Citri Reticulatae Pericarpium-Pinelliae Rhizoma in the
treatment of gastric cancer. Evid Based Complement Alternat Med.
2021:66675602021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ayeka PA, Bian Y, Githaiga PM and Zhao Y:
The immunomodulatory activities of licorice polysaccharides
(Glycyrrhiza uralensis Fisch.) in CT 26 tumor-bearing mice.
BMC Complement Altern Med. 17:5362017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Park A, Yang Y, Lee Y, Jung H, Kim TD, Noh
JY, Lee S and Yoon SR: Aurantii Fructus Immaturus enhances
natural killer cytolytic activity and anticancer efficacy in vitro
and in vivo. Front Med (Lausanne). 9:9736812022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ding J, Chua PJ, Bay BH and
Gopalakrishnakone P: Scorpion venoms as a potential source of novel
cancer therapeutic compounds. Exp Biol Med (Maywood). 239:387–393.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Rapôso C: Scorpion and spider venoms in
cancer treatment: State of the art, challenges, and perspectives. J
Clin Transl Res. 3:233–249. 2017.PubMed/NCBI
|
|
53
|
Zhao H, Li Y, Wang Y, Zhang J, Ouyang X,
Peng R and Yang J: Antitumor and immunostimulatory activity of a
polysaccharide-protein complex from Scolopendra subspinipes
mutilans L. Koch in tumor-bearing mice. Food Chem Toxicol.
50:2648–2655. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Bokhari AA and Syed V: Inhibition of
transforming growth factor-β (TGF-β) signaling by Scutellaria
baicalensis and Fritillaria cirrhosa Extracts in
endometrial cancer. J Cell Biochem. 116:1797–1805. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cao S, Zheng B, Chen T, Chang X, Yin B,
Huang Z, Shuai P and Han L: Semen Brassicae ameliorates hepatic
fibrosis by regulating transforming growth factor-β1/Smad, nuclear
factor-κB, and AKT signaling pathways in rats. Drug Des Devel Ther.
12:1205–1213. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Xiao Y, Wei P, Li Y, He J, Xu L and Qin Z:
Influence of Xiaotan Sanjie decoction on the expression of matrix
metalloproteinase and inhibitor in Gastric Carcinoma. Hubei J
Tradit Chin Med. 34:8–10. 2005.
|
|
57
|
Ju D, Xiu L, Sun D, Lu Y and Wei P:
Effects of Xiaotan Sanjie decoction on invasive ability of human
gastric cancer cell line SGC-7901. Chin J Woman Child Health Res.
27:343–344. 2016.(In Chinese).
|
|
58
|
Tang J, Wei P and Zhang Y: Effects of
Xiaotan Sanjie decoction on microvessel density and expression
level of VEGF-A/VEGFR-2. World J Integr Tradit Western Med.
10:346–349. 2015.
|
|
59
|
Xu L, Su X, Chen Y and Wei P: Xiaotan
Sanjie decoction downregulate expression level of VEGF, KDRmRNA in
orthotopic human gastric carcinoma in nude mice. World Chin J
Digest. 12:32004.(In Chinese).
|
|
60
|
Pang B, Wei P, Mao Z and Li Y: Effects of
Xiaotan Sanjie Decoction on expression levels of VEGF-D in MKN45
×enografts in nude mice. Chin J Inf Tradit Chin Med. 18:42–44.
2011.(In Chinese).
|
|
61
|
Zhou W, Li YJ and Wei PK: Effects of
xiaotan sanjie decoction on vasculogenic mimicry of human gastric
cancer xenografts in nude mice. Zhongguo Zhong Xi Yi Jie He Za Zhi.
31:532–536. 2011.(In Chinese). PubMed/NCBI
|
|
62
|
Kumar V, Ramnarayanan K, Sundar R,
Padmanabhan N, Srivastava S, Koiwa M, Yasuda T, Koh V, Huang KK,
Tay ST, et al: Single-cell atlas of lineage states, tumor
microenvironment, and subtype-specific expression programs in
gastric cancer. Cancer Discov. 12:670–691. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Gu J, Wang C, Xu X, Zhao L, Zhou J, Bai C
and Sun Z: Immunohistochemical detection of cancer-associated
fibroblasts in gastrointestinal cancer as a potential prognostic
biomarker of survival: Meta-analysis. Transl Cancer Res.
9:6629–6638. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wen X, He X, Jiao F, Wang C, Sun Y, Ren X
and Li Q: Fibroblast activation Protein-a-positive fibroblasts
promote gastric cancer progression and resistance to immune
checkpoint blockade. Oncol Res. 25:629–640. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yu Z, Zhao Y, Hu X, Shao Z, Jiang Z, Lu Y,
Xiao Z, Pang B, et al: Effects of Xiaotan Sanjie decoction on
expression of fibroblast activation protein α in gastric cancer
MKN-45 cells xenografted in nude mice. Chin Arch Tradit Chin Med.
28:331–334. 2010.(In Chinese). https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFD2010&filename=ZYHS201002050&v=CTYLMbKoZXwaH0%25mmd2FV8SFqFzODQhR2nxC%25mmd2FPoPnpAkNeO7fQrS0ZGsv7vUfMkTs49D0
|
|
66
|
French R, Feng Y and Pauklin S: Targeting
TGFβ signaling in cancer: Toward context-specific strategies.
Trends Cancer. 6:538–540. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Saito H, Tsujitani S, Oka S, Kondo A,
Ikeguchi M, Maeta M and Kaibara N: An elevated serum level of
transforming growth factor-beta 1 (TGF-beta 1) significantly
correlated with lymph node metastasis and poor prognosis in
patients with gastric carcinoma. Anticancer Res. 20:4489–4493.
2000.PubMed/NCBI
|
|
68
|
Evans RA, Tian YC, Steadman R and Phillips
AO: TGF-β1-mediated fibroblast-myofibroblast terminal
differentiation-the role of smad proteins. Exp Cell Res.
282:90–100. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Yang L, Chang N, Liu X, Han Z, Zhu T, Li
C, Yang L and Li L: Bone marrow-derived mesenchymal stem cells
differentiate to hepatic myofibroblasts by transforming growth
factor-β1 via sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P
receptor axis. Am J Pathol. 181:85–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Jotzu C, Alt E, Welte G, Li J, Hennessy
BT, Devarajan E, Krishnappa S, Pinilla S, Droll L and Song YH:
Adipose tissue derived stem cells differentiate into
carcinoma-associated fibroblast-like cells under the influence of
tumor derived factors. Cell Oncol (Dordr). 34:55–67. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Calon A, Tauriello DV and Batlle E:
TGF-beta in CAF-mediated tumor growth and metastasis. Semin Cancer
Biol. 25:15–22. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Piek E, Heldin CH and Ten Dijke P:
Specificity, diversity, and regulation in TGF-beta superfamily
signaling. FASEB J. 13:2105–2124. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Massagué J, Seoane J and Wotton D: Smad
transcription factors. Gene Dev. 19:2783–2810. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Elliott RL and Blobe GC: Role of
transforming growth factor Beta in human cancer. J Clin Oncol.
23:2078–2093. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Pickup M, Novitskiy S and Moses HL: The
roles of TGFβ in the tumour microenvironment. Nat Rev Cancer.
13:788–799. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Bierie B and Moses HL: TGF-β and cancer.
Cytokine Growth Factor Rev. 17:29–40. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Park K, Kim SJ, Bang YJ, Park JG, Kim NK,
Roberts AB and Sporn MB: Genetic changes in the transforming growth
factor beta (TGF-beta) type II receptor gene in human gastric
cancer cells: Correlation with sensitivity to growth inhibition by
TGF-beta. Proc Natl Acad Sci USA. 91:8772–8776. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Nadauld LD, Garcia S, Natsoulis G, Bell
JM, Miotke L, Hopmans ES, Xu H, Pai RK, Palm C, Regan JF, et al:
Metastatic tumor evolution and organoid modeling implicate TGFBR2
as a cancer driver in diffuse gastric cancer. Genome Biol.
15:4282014. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kim SH, Lee SH, Choi YL, Wang LH, Park CK
and Shin YK: Extensive alteration in the expression profiles of
TGFB pathway signaling components and TP53 is observed along the
gastric dysplasia-carcinoma sequence. Histol Histopathol.
23:1439–1452. 2008.PubMed/NCBI
|
|
80
|
Pak KH, Kim DH, Kim H, Lee DH and Cheong
JH: Differences in TGF-β1 signaling and clinicopathologic
characteristics of histologic subtypes of gastric cancer. BMC
Cancer. 16:602016. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yan YQ, Xie J, Wang JF, Shi ZF, Zhang X,
Du YP and Zhao XC: Scorpion inhibits epithelial-mesenchymal
transition and metastasis of hepatocellular carcinoma. Exp Biol Med
(Maywood). 243:645–654. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Karakasheva TA, Lin EW, Tang Q, Qiao E,
Waldron TJ, Soni M, Klein-Szanto AJ, Sahu V, Basu D, Ohashi S, et
al: IL-6 mediates cross-talk between tumor cells and activated
fibroblasts in the tumor microenvironment. Cancer Res.
78:4957–4970. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Ju D, Wei P, Sun D, Lin H and Yu S:
Effects of Xiaotan Sanjie decoction on IL-6 gene expression in
tumor and adjacent tissues of S180 tumor-bearing mice model. Chin J
Integr Dig. 15:284–288. 2008.(In Chinese).
|
|
84
|
Li S, Zheng M, Zhang Z, Peng H, Dai W and
Liu J: Galli gigeriae endothelium corneum: Its intestinal barrier
protective activity in vitro and chemical composition. Chin Med.
16:222021.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Yu JY, Ha JY, Kim KM, Jung YS, Jung JC and
Oh S: Anti-Inflammatory activities of licorice extract and its
active compounds, glycyrrhizic acid, liquiritin and liquiritigenin,
in BV2 cells and mice liver. Molecules. 20:13041–13054. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Kitadai Y, Takahashi Y, Haruma K, Naka K,
Sumii K, Yokozaki H, Yasui W, Mukaida N, Ohmoto Y, Kajiyama G, et
al: Transfection of interleukin-8 increases angiogenesis and
tumorigenesis of human gastric carcinoma cells in nude mice. Br J
Cancer. 81:647–653. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Wang Z, Hou Y, Yao Z, Zhan Y, Chen W and
Liu Y: Expressivity of Interleukin-8 and gastric cancer prognosis
susceptibility: A systematic review and meta-analysis. Dose
Response. 19:155932582110371272021. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Zhai J, Shen J, Xie G, Wu J, He M, Gao L,
Zhang Y, Yao X and Shen L: Cancer-associated fibroblasts-derived
IL-8 mediates resistance to cisplatin in human gastric cancer.
Cancer Lett. 454:37–43. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Shi J and Wei PK: Xiaotan Sanjie decoction
inhibits interleukin-8-induced metastatic potency in gastric
cancer. World J Gastroenterol. 21:1479–1487. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lynch MD and Watt FM: Fibroblast
heterogeneity: Implications for human disease. J Clin Investig.
128:26–35. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Voloshenyuk TG, Landesman ES, Khoutorova
E, Hart AD and Gardner JD: Induction of cardiac fibroblast lysyl
oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling.
Cytokine. 55:90–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Najafi M, Farhood B and Mortezaee K:
Extracellular matrix (ECM) stiffness and degradation as cancer
drivers. J Cell Biochem. 120:2782–2790. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Huang J, Zhang L, Wan D, Zhou L, Zheng S,
Lin S and Qiao Y: Extracellular matrix and its therapeutic
potential for cancer treatment. Signal Transduct Target Ther.
6:1532021. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Balazs EA, Laurent TC and Jeanloz RW:
Nomenclature of hyaluronic acid. Biochem J. 235:9031986. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Setälä LP, Tammi MI, Tammi RH, Eskelinen
MJ, Lipponen PK, Agren UM, Parkkinen J, Alhava EM and Kosma VM:
Hyaluronan expression in gastric cancer cells is associated with
local and nodal spread and reduced survival rate. Br J Cancer.
79:1133–1138. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Eikenes L, Tufto I, Schnell EA, Bjørkøy A
and De Lange Davies C: Effect of collagenase and hyaluronidase on
free and anomalous diffusion in multicellular spheroids and
xenografts. Anticancer Res. 30:359–368. 2010.PubMed/NCBI
|
|
97
|
Jacobetz MA, Chan DS, Neesse A, Bapiro TE,
Cook N, Frese KK, Feig C, Nakagawa T, Caldwell ME, Zecchini HI, et
al: Hyaluronan impairs vascular function and drug delivery in a
mouse model of pancreatic cancer. Gut. 62:112–120. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Zhao R, Cui Y, Zheng Y, Li S, Lv J, Wu Q,
Long Y, Wang S, Yao Y, Wei W, et al: Human Hyaluronidase PH20
potentiates the antitumor activities of Mesothelin-specific CAR-T
cells against gastric cancer. Front Immunol. 12:6604882021.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Wright RP, Chan TK, Honetschlager L,
Howell DE and Odell GV: Enzymes and toxins of the scorpion venom
Palamneus gravimanus. Toxicon. 15:197–205. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
González-Morales L, Pedraza-Escalona M,
Diego-Garcia E, Restano-Cassulini R, Batista CV, Gutiérrez Mdel C
and Possani LD: Proteomic characterization of the venom and
transcriptomic analysis of the venomous gland from the Mexican
centipede Scolopendra viridis. J Proteomics. 111:224–237. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Naor D, Sionov RV and Ish-Shalom D: CD44:
Structure, function, and association with the malignant process.
Adv Cancer Res. 71:241–319. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Chen Y, Fu Z, Xu S, Xu Y and Xu P: The
prognostic value of CD44 expression in gastric cancer: A
meta-analysis. Biomed Pharmacother. 68:693–697. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Misra S, Heldin P, Hascall VC, Karamanos
NK, Skandalis SS, Markwald RR and Ghatak S: Hyaluronan-CD44
interactions as potential targets for cancer therapy. FEBS J.
278:1429–1443. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Zhang S, Wei P, He J, Xiao Y, Chen G, Gu
J, et al: Effects of Jinlongshe formula on tumor proliferation and
metastases and expression of cell adhesion molecules in MKN-45
human gastric cancer nude mouse model. Tumor. 25:519–524.
2006.https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFD2006&filename=ZZLL200606006&v=s1YASjhB7tsvRqd%25mmd2F%25mmd2BMg%25mmd2Fq8XnD2Vn96oB%25mmd2BffZf4A4Bh7qvD40ECTEqijOPzzUCyqD
|
|
105
|
Lukaszewicz-Zając M, Mroczko B and
Szmitkowski M: Gastric cancer- The role of matrix
metalloproteinases in tumor progression. Clin Chim Acta.
412:1725–1730. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Fukumura D, Xavier R, Sugiura T, Chen Y,
Park EC, Lu N, Selig M, Nielsen G, Taksir T, Jain RK and Seed B:
Tumor induction of VEGF promoter activity in stromal cells. Cell.
94:715–725. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Zhao Y, Wang X, Lu Y, Liu X, Xiu L, Yue X,
et al: Xiaotan Sanjie decoction on quality of life in patients with
advanced gastric cancer. Ti Erh Chun I Ta Hsueh Hsueh Pao.
37:1333–1337. 2016.(In Chinese). https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFDLAST2017&filename=DEJD201611003&v=kQr6y0QoJCwsnabe8RyD3I5ziphgCCMRnPcPGOv3wTJP8Apz2l2jK77cElywgR16
|
|
108
|
Wu F, Qin Z, Zhang C, Yan B, Shen W and
Wei P: Effects of Jinlongshe formulae on quality of life in
patients with gastric cancer after gastric resection. Chin J Integr
Tradit Western Med Digest. 20:289–292. 2012.(In Chinese).
|
|
109
|
Shi J, Qin Z, Wang X, Zhang Y, Zhang C,
Wang D, et al: Xiaotan Sanjie decoction in patients with gastric
cancer after gastric resection. Chin J Info Tradit Chin Med.
18:14–17. 2011.(In Chinese). https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFD2011&filename=XXYY201110010&v=WYxc3H1bWPb2I7WrEYpn3%25mmd2Bq7b0lH46oPvMqfiqxL2Kfg7dCZ%25mmd2FVE4dYKAbMYdugZR
|
|
110
|
Li X and Wei P: Jinlongshe formulae in
advanced gastric cancer. Hubei J Tradit Chin Med. 23:3–5. 2001.(In
Chinese).
|
|
111
|
Xu L, Chen Y, Liu Y, Qin Z, Li J, Shi J,
et al: Efficacy of Xiaotan Sanjie decoction combined with Huangqi
injection and Huachansu injection in patients with stage IV gastric
cancer. J Chengdu Univ Tradit Chin Med. 28:7–9. 2005.(In Chinese).
https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C44YLTlOAiTRKgchrJ08w1e7F1IFNsBV5UtixLZQlfT5Bp4RioHTO7MFcAQH76h6XVw4s4ZTzR4S80OigHx_bgBm&uniplatform=NZKPT
|
|
112
|
Sun DZ, Jiao JP, Zhang X, Xu JY, Ye M, Xiu
LJ, Zhao Y, Lu Y, Liu X, Zhao J, et al: Therapeutic effect of
Jinlongshe granule on quality of life of stage IV gastric cancer
patients using EORTC QLQ-C30: A double-blind placebo-controlled
clinical trial. Chin J Integr Med. 21:579–586. 2015.(In Chinese).
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Liu X, Xiu LJ, Jiao JP, Zhao J, Zhao Y, Lu
Y, Shi J, Li YJ, Ye M, Gu YF, et al: Traditional Chinese medicine
integrated with chemotherapy for stage IV non-surgical gastric
cancer: A retrospective clinical analysis. J Integr Med.
15:469–475. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Sun DZ, Ju DW, He J, Lu Y, Wu F, Li C and
Wei PK: Tumor interstitial fluid and postoperative recurrence of
tumors: An experimental study for verifying hypothesis of
‘Tumor-phlegm Microenvironment’. Chin J Integr Med. 16:435–441.
2010.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Koelzer VH, Sirinukunwattana K, Rittscher
J and Mertz KD: Precision immunoprofiling by image analysis and
artificial intelligence. Virchows Archiv. 474:511–522. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Lin L and Wang LV: The emerging role of
photoacoustic imaging in clinical oncology. Nat Rev Clin Oncol.
19:365–384. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Qi CY, Wang J, Wu X, He SR, Zhang Q, Wu JH
and Zhao CB: Botanical, traditional use, phytochemical, and
toxicological of Arisaematis rhizoma. Evid Based Complement
Alternat Med. 2021:90555742021. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Wang Y, Li T, Zhao Y, Zhang J and Liu H:
Contents of some metabolites in the peel and flesh of the medicinal
mushroom Wolfiporia cocos (F.A. Wolf) Ryvarden et
Gilb. (Higher Basidiomycetes). Int J Med Mushrooms.
14:79–83. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Bian C, Xie N and Chen F: Preparation of
bioactive water-soluble pachyman hydrolyzed from sclerotial
polysaccharides of Poria cocos by hydrolase. Polym J.
42:256–260. 2010. View Article : Google Scholar
|
|
120
|
Wagner H, Püls S, Barghouti T, Staudinger
A and Melchart D: Chromatographic Fingerprint Analysis of Herbal
Medicines. Springer; Vienna: pp. 31–44. 2018
|
|
121
|
Duan L, Guo L, Liu K, Liu EH and Li P:
Characterization and classification of seven citrus herbs by liquid
chromatography-quadrupole time-of-flight mass spectrometry and
genetic algorithm optimized support vector machines. J Chromatogr
A. 1339:118–127. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Hao EW, Su ZX, Gong YL, Du ZC, Yang X,
Huang CT, Hou XT and Deng JG: Analysis on application law of
dampness-removing traditional Chinese medicines in treatment of
coronavirus disease 2019. Chin Herb Med. 13:518–524. 2021.(In
Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Song L, Xiong P, Zhang W, Hu H, Tang S,
Jia B and Huang W: Mechanism of Citri Reticulatae
Pericarpium as an anticancer agent from the perspective of
flavonoids: A review. Molecules. 27:56222022. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Moon JY and Cho SK: Nobiletin Induces
protective autophagy accompanied by ER-stress mediated apoptosis in
human gastric cancer SNU-16 cells. Molecules. 21:9142016.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Dong Y, Cao A, Shi J, Yin P, Wang L, Ji G,
Xie J and Wu D: Tangeretin, a citrus polymethoxyflavonoid, induces
apoptosis of human gastric cancer AGS cells through extrinsic and
intrinsic signaling pathways. Oncol Rep. 31:1788–1794. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Yu W, Xie X, Yu Z, Jin Q and Wu H:
Mechanism of hesperidin-induced apoptosis in human gastric cancer
AGS cells. Trop J Pharm Res. 50:2363–2369. 2019.
|
|
127
|
Xiong Q, Li X, Zhou R, Hao H, Li S, Jing
Y, Zhu C, Zhang Q and Shi Y: Extraction, characterization and
antioxidant activities of polysaccharides from E. corneum
gigeriae galli. Carbohydr Polym. 108:247–256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Chen T, Zhong F, Yao C, Chen J, Xiang Y,
Dong J, Yan Z and Ma Y: A systematic review on traditional uses,
sources, phytochemistry, pharmacology, pharmacokinetics, and
toxicity of Fritillariae Cirrhosae Bulbus. Evid Based
Complement Alternat Med. 2020:15365342020. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Wang D, Chen X, Atanasov AG, Yi X and Wang
S: Plant resource availability of medicinal Fritillaria
species in traditional producing regions in Qinghai-Tibet plateau.
Front Pharmacol. 8:5022017. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Li R, Zhang Y, Wang Y, Huang K, Yang Q,
Zhang T, Xie K, Li J and Zhao Q: Aqueous extract of Fritillariae
cirrhosae induces cellular apoptosis through activation of
STATs-mediated immunomodulation. J Ethnopharmacol. 261:1123382020.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Wang X, Zhang H, Chen L, Shan L, Fan G and
Gao X: Liquorice, a unique ‘guide drug’ of traditional Chinese
medicine: A review of its role in drug interactions. J
Ethnopharmacol. 150:781–790. 2013. View Article : Google Scholar : PubMed/NCBI
|
